Point of care testing for Coeliac disease
Purins, A, Mundy L, Hiller JE
Record ID 32008100170
English
Authors' results and conclusions:
The point-of-care tests, particularly the Biocard test, were rapid and easy to use and provided accurate results compared to the gold standards of coeliac disease (CD) diagnosis. They may fill several roles in the future including screening, diagnosis and CD monitoring in diagnosed populations. Additionally, the tests were relatively cheap and did not require any special infrastructure or training to use. Given that effective management of CD exists the identification of more CD patients is a worthwhile goal.
Authors' recommendations:
The point-of-care tests included in this summary appear to be an effective tool for the diagnosis of coeliac disease. These tests do not require approval from the Therapeutic Goods Administration (TGA) and may be used by general practitioners. Therefore HealthPACT recommend that the information contained within this summary is disseminated and that no further action is warranted.
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Point-of-Care Systems
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.